Effects of liraglutide on cardiovascular outcomes in patients with diabetes with or without heart failure

Abstract

The effects of liraglutide on cardiovascular events and mortality in LEADER participants were investigated. The study concluded that liraglutide is suitable for patients with T2D with or without HF.

Citation
Marso SP, Baeres FMM, Bain SC, et al. J Am Coll Cardiol 2020;75:1128–41.